Supplementary Figure 1 S1. Tetracyclin inducible promoter suppresses its downstream gene expression, resulting in non-observable growth. (a) tetO2Rpn8 and tetO2Rpn11 were serially inoculated in the YPD plates containing 20μg/ml tetracyclin. (b). After treatment of tetracyclin for overnight, the cells as indicated were inoculated to fresh YPD to check the viability. b. a. -WT -tetO2RPN8 -tetO2RPN11 -WT -tetO2RPN8 -tetO2RPN11 FIGURE S1 Supporting Information for "Proteasome Lid formation Yu Z et al. 3 Supplementary Figure 2 S2. Super-long term treatment of tetracyclin leads to break of proteasome. The yeast strain tetO2RPN8 and tetO2RPN11were treated by 20ug/ml tetracyclin for longer period of time as indicated. Supplementary Figure 3
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S2. Super-long term treatment of tetracyclin leads to break of proteasome. The yeast strain tetO2RPN8 and tetO2RPN11were treated by 20ug/ml tetracyclin for longer period of time as indicated.
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S3. Either N-terminus or C-terminus doesn't rescue the lethality due to the suppression of RPN8 or RPN11 (a) Plasmid containing the RPN8 domains as indicated under control of ADH promoter was inducted into the background strain tetO 2 RPN8, the cells were inoculated onto plates containing 20μg/ml tetracyclin in a serial dilution. (b) Plasmid containing the RPN11 domains as indicated under control of ADH promoter was inducted into the background strain tetO2RPN11, the cells were inoculated onto plates containing 20μg/ml tetracyclin in a serial dilution. tetO2RPN8 0 12 24 24 0 12 24 0 12 24
WT tetO2RPN11 WT
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Yeast strain list
This study The list contains all the plasmid used in this study.
The genetic background of the yeast strains used in this study is based on BY4741 Plasmid list:
Number Gene
Vector Origin M1364 Rpn5, Rpn6, Rpn8, Rpn9, his6-Rpn11 petDuet (7) M1335 his6-Rpn11 pQE30 this study M1388 Rpn8, his6-Rpn11 petDuet this study M1398 Rpn5, Rpn8, his6-Rpn11 petDuet this study M1397 Rpn5, Rpn8, Rpn9, his6-Rpn11 petDuet this study M1400 Rpn6, Rpn8, Rpn9, his6-Rpn11 petDuet this study M1386 Rpn5, Rpn6, Rpn8, his6-Rpn11 petDuet this study M1403 Rpn5, Rpn6, Rpn9, his6-Rpn11 petDuet this study M1109 Rpn11 C-terminus pQE30 this study M899 Rpn11 C-terminus pRS425 (8) The list contains all the plasmid used in this study.
Methods and Materials in MS/MS analysis Proteasome resolusion
Whole cell extract from yeast cells was resolved by 4% nondenaturing-PAGE (9) .
The peptidase activity based on LLVY-AMC tracing was the marker for cutting the gel slices. The native gel slices were modified with 100 mM iodoacetamide in 10 mM ammonium bicarbonate (room temperature for 30min) and trypsinized in 10 mM ammonium bicarbonate containing trypsin [modified trypsin (Promega)] at a 1:50 enzyme-to-substrate ratio, overnight at 37°C.
Mass spectrometry analysis
The resulting tryptic peptides were resolved by reverse-phase chromatography on 0.075 X 200-mm fused silica capillaries (J&W) packed with Reprosil reversed phase material (Dr Maisch GmbH, Germany). The peptides were eluted with linear 65 minutes gradients of 5 to 45% and 15 minutes at 95% acetonitrile with 0.1% formic acid in water at flow rates of 0.25 μl/min. Mass spectrometry was performed by an ion-trap mass spectrometer (Orbitrap, Thermo) in a positive mode using repetitively full MS scan followed by collision induces dissociation (CID) of the 7 most dominant ion selected from the first MS scan.
Database search
The mass spectrometry data was analyzed using the Trans Proteomic Pipeline (TPP) 
